Soparkar Peter
- SEC CIK
- 0001736315
In the past year, 1 open-market purchase filing worth $211.0K and no sales.
Current role at each company
- ADVM Adverum Biotechnologies, Inc.CHIEF OPERATING OFFICERas of Dec 10, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $211.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$211.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Soparkar Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 (view filing) | Dec 5 | 3 days | Soparkar PeterCHIEF OPERATING OFFICER | PPurchase | +50.0K | $4.22 | +$211.0K | +165.6%80.2K after | |
| May 16, 2025 (view filing) | May 15 | 1 day | Soparkar PeterCHIEF OPERATING OFFICER | SSale | −2.96K | $2.00 | −$5.92K | −7.0%39.2K after | |
| Mar 17, 2023 (view filing) | Mar 15 | 2 days | Soparkar PeterChief Operating Officer | SSale | −13.4K | $0.78 | −$10.4K | −4.8%265.9K after | |
| Sep 21, 2022 (view filing) | Sep 19 | 2 days | Soparkar PeterSee Remarks section | SSale | −13.3K | $1.07 | −$14.2K | −4.6%273.3K after | |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Soparkar PeterSee Remarks section | PPurchase | +21.9K | $1.14 | +$25.0K | +8.5%280.6K after | 2 lots |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Soparkar PeterSee Remarks section | PPurchase | +25.0K | $1.91 | +$47.8K | +10.7%258.6K after |